https://canceradvocacy.org/wp-content/uploads/2019/10/Canceradvocacy-org-default-image.jpg
600
1200
NCCS Staff
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
NCCS Staff2021-02-25 17:48:242021-03-04 18:07:26NCCS Joins Patient, Disability, and Health Care Organizations to Urge U.S. Supreme Court to Protect Medicaid and Rule Against Work RequirementsNews
https://canceradvocacy.org/wp-content/uploads/2019/10/Canceradvocacy-org-default-image.jpg
600
1200
NCCS Staff
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
NCCS Staff2021-02-25 17:48:242021-03-04 18:07:26NCCS Joins Patient, Disability, and Health Care Organizations to Urge U.S. Supreme Court to Protect Medicaid and Rule Against Work Requirements
https://canceradvocacy.org/wp-content/uploads/2019/10/Canceradvocacy-org-default-image.jpg
600
1200
NCCS Staff
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
NCCS Staff2021-02-24 21:01:392021-02-24 21:01:39National Quality Forum Names NCCS CEO Shelley Fuld Nasso to 2021 Leadership Consortium Roster
https://canceradvocacy.org/wp-content/uploads/HHS-Health-Human-Services-Humphrey-Building.jpg
600
1200
NCCS Staff
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
NCCS Staff2021-02-19 15:06:392025-04-16 04:12:39NCCS and Other Cancer Groups Urge HHS to Keep Six Protected Classes in Medicare Part D Drug Plans
https://canceradvocacy.org/wp-content/uploads/CDC-Website.jpg
600
1200
NCCS Staff
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
NCCS Staff2021-01-28 22:34:532021-01-28 22:42:08NCCS Urges CDC Committee to Include Cancer Survivors in High-Risk Category for COVID-19 Vaccine Distribution
https://canceradvocacy.org/wp-content/uploads/2017/10/HHS-Humphrey-bldg-1200.jpg
600
1200
NCCS Staff
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
NCCS Staff2020-12-22 20:27:262021-01-04 21:38:15NCCS, Cancer Groups Urge CMS to Withdraw Most Favored Nation (MFN) Medicare Part B Rule That Will Harm Patients and Reduce Access to Care
https://canceradvocacy.org/wp-content/uploads/HHS-Health-Human-Services-Building-Doors.jpg
600
1200
NCCS Staff
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
NCCS Staff2020-12-09 17:30:502025-04-16 04:13:18NCCS Letter to HHS: Proposed Regulatory Review Rule Would Create Unnecessary Uncertainty for Patients
https://canceradvocacy.org/wp-content/uploads/HHS-Humphrey-bldg-1200.jpg
600
1200
NCCS Staff
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
NCCS Staff2020-12-03 21:26:462021-11-02 08:19:15NCCS Opposes Most Favored Nation (MFN) Rule: New Medicare Part B Drug Payment Model Will Harm Patients
https://canceradvocacy.org/wp-content/uploads/Stovall-Award-2020-feat2.jpg
635
1200
NCCS Staff
https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png
NCCS Staff2020-11-19 01:07:452021-03-31 14:50:29NCCS Presents 5th Annual Ellen L. Stovall Award to Julia H. Rowland, PhD and Thomas J. Smith, MD for Their Innovation and Dedication to Cancer Survivors
